Upcoming Live Meeting Series! Paradigmmed.org/1384-5zoom Paradigmmed.org/1384-6zoom Join us for Managing IDH & FLT3-Mutant AML: Precision in Practice. October 28, 2026 | 1:00 PM EDT November 4, 2026 | 5:00 PM EST Register Now! We look forward to having you join us!

COMPLIMENTARY CME! View this interactive match game that compares trial versus real-world data for second-generation retinal therapies in patients with DME or nAMD. paradigmmed.org/1464SM

View this NEW CME-accredited webinar to hear how leading clinicians align treatment decisions with patient goals, integrate multiple modalities, and apply emerging agents and techniques in practice. Link in Bio or Scan QR code to view now! paradigmmed.org/1462w

View Now! Join our expert faculty as they discuss how IDH and FLT3 mutations shape AML prognosis and treatment. Hear expert insights on targeted therapies, sequencing, resistance, and precision medicine strategies for better patient outcomes. Https://paradigmmed.org/1384…

REGISTRATION NOW OPEN! paradigmmed.org/1487LIVECC LIVE/VIRTUAL STREAMING SYMPOSIUM Friday, December 11, 2026 Registration and Dinner: 11:30 AM – 12:00 PM CT Symposium: 12:00 PM – 1:30 PM CT Location: New Orleans Ernest N. Morial Convention Center

FREE CME! Our expert faculty offers a robust, case-based conversation about the landscape, benefits, risks, and appropriate use of sustained-release prostaglandin analog therapy in the management of glaucoma, ... Https://paradigmmed.org/1404…

Upcoming Live Meeting Series! paradigmmed.org/1384-5zoom paradigmmed.org/1384-6zoom Join us for Managing IDH & FLT3-Mutant AML: Precision in Practice. 📌 October 28, 2026 | 1:00 PM EDT 📌 November 4, 2026 | 5:00 PM EST Register Now! We look forward to having you join us!

FREE CME! Join us for a lively discussion on targeting B cells in the treatment of lupus nephritis, including the latest clinical data, new guidelines, and incorporating new agents into therapy. Check it out! Link in bio or scan QR code paradigmmed.org/1394-2SM

View this NEW CME-accredited webinar to hear how leading clinicians align treatment decisions with patient goals, integrate multiple modalities, and apply emerging agents and techniques in practice. Link in Bio or Scan QR code to view now! paradigmmed.org/1462w

Free CME! Join this webinar to gain insights into best practices for switching and sequencing anti-vascular endothelial growth factor (VEGF) therapies for neovascular age-related macular degeneration (nAMD).... Paradigmmed.org/1416-4SM

REGISTRATION NOW OPEN! paradigmmed.org/1490LIVECC LIVE/VIRTUAL STREAMING SYMPOSIUM Friday, December 11, 2026 Registration and Dinner: 7:00 PM – 7:30 PM CT Symposium: 7:30 PM – 9:00 PM CT 📍Location: New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd

FREE CME! The treatment of nonrenal systemic lupus erythematosus (SLE) is expected to evolve as new agents emerge for treatment. Link in bio or Scan QR code paradigmmed.org/1477SM

That’s a Wrap! Thank you to our faculty for sharing your expertise and to everyone who joined us in New Orleans and via live stream!

HAPPENING TODAY! Don’t miss out! Join us! LIVE/LIVE STREAMING SYMPOSIUM We look forward to seeing you in New Orleans! CAN’T MAKE IT TO NEW ORLEANS? WE HAVE LIVE STREAMING OPTION TO PARTICIPATE VIRTUALLY. Link in Bio or Scan QR code Https://paradigmmed.org/1514…

Complimentary CME - View Now! Join experts as they demonstrate the role of innovative sustained delivery therapies in this dynamic, case-based, simulation-enhanced program featuring practical management strategies tailored for busy retina clinics. paradigmmed.org/1420SM

FREE CME! VIEW NOW! In this Points of View webinar, a patient case highlights the challenge of treating macular edema secondary to retinal vein occlusion (RVO).... Https://paradigmmed.org/1403…

Free CME! Tune in for a lively discussion among the faculty on the categories of B-cell therapies from blocking activation, B-cell depletion, to CAR-T cells, efficacy, safety, and the potential uses of emerging agents. paradigmmed.org/1460SM

FREE NEW CME! Are misconceptions about sustained delivery therapy limiting your patients’ outcomes? Find out as experts address common myths head on to clarify patient eligibility, durability, safety, and clinical application versus the standard of care. paradigmmed.org/1470SM

LAST CHANCE! Join us! Our faculty discusses treatment options for nAMD and DME/DR, including sustained delivery therapies such as ranibizumab PDS, TKIs, and gene therapy, and how to optimize treatment selection for improved patient outcomes. paradigmmed.org/1374INS

FREE CME! Don’t miss this expert-led, case- and video-enhanced exploration of the latest advances in sustained delivery that are transforming retinal vascular disease treatment while reducing burden on both patients and practices. paradigmmed.org/1456-2SM